Trademark Overview
On Tuesday, April 15, 2025, a trademark application was filed for CAMFLIO with the United States Patent and Trademark Office. The USPTO has given the CAMFLIO trademark a serial number of 99137937. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 15, 2025. This trademark is owned by Glaxo Group Limited. The CAMFLIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Anti-infectives; Vaccines